HONOLULU, Hawaii -- David Toms and Chad Campbell were named this week’s AstraZeneca Charity Challenge winners as the two were tied for the lead at 14-under-par 196 entering the final round of the Sony Open in Hawaii. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities, bringing the total donated to charity since the program's inception in 2004 to $9.7 million.

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year's sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

AstraZeneca will donate $100,000 to The American College of Gastroenterology in the names of Toms and Campbell, and the Sony Open in Hawaii.

"The American College of Gastroenterology and its digestive health specialists are committed to quality patient care through education and research," said Jack A. DiPalma, M.D., ACG's President. "We are grateful for the generous support of the AstraZeneca Charity Challenge in advancing the College's mission of enhancing awareness of digestive diseases and promoting life-saving screening for colorectal cancer."

"AstraZeneca's partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America," said Tony Zook, CEO, AstraZeneca U.S. "The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday."

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program.

Highlights from the AZCC include:

• Stuart Appleby was the AstraZeneca Charity Challenge winner at last weekend’s Mercedes Championships.

• More than 80 charities benefited from the program.

• Vijay Singh leads all players with eight AstraZeneca Charity Challenge wins. With some of his charitable "winnings," Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans.

• Multiple winners have included Tom Lehman (four), Phil Mickelson (three), and the following players who triumphed twice: Stuart Appleby, Bart Bryant, Chris DiMarco, Luke Donald, Jim Furyk, Sergio Garcia, Joe Ogilvie, Kenny Perry, Carl Petterson, Ted Purdy, Adam Scott and David Toms.

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

About The American College of Gastroenterology
The American College of Gastroenterology (ACG) was founded in 1932 to advance the scientific study and medical practice of diseases of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the individual and collective needs of clinical GI practitioners.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world's leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products.

AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca's R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.